| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.08 | 0.06 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.06 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.06 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.32 | 0.06 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.12 | 0.07 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.07 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.07 |